Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
Medtronic's latest partnership with Merit Medical Systems introduces the groundbreaking ViaVerte™ BVNA system—an innovative solution for chronic vertebrogenic pain
Led by researchers at the Vanderbilt University Medical Center, a new study reports that Optellum's FDA-cleared Lung Cancer Prediction (LCP) AI assisted risk stratification for indeterminate lung nodules is cost-effective from a US payer perspective. Optellum's LCP AI supports more consistent long nodule management and helps enable earlier diagnosis of...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD
The study, published in The March 2026 edition of Federal Practitioner, reported an association between thermal therapy use and reduced opioid and benzodiazepine utilization, as well as lower healthcare utilization in the patient population.
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including slower functional decline, reduced risk of ALS-related complications, and modulation of disease-relevant biomarkers
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
Redipor® Legionella agar plate range - specifically designed to support the detection and enumeration of Legionella in water samples
This significant funding will fuel the continued expansion of Glytec’s platform, including its flagship Glucommander® SaaS solution, accelerate the development of innovative new technologies to address the growing global health crisis of diabetes and related co-morbidities, and support the continued rapid response to upcoming CMS quality measures that will hold health systems accountable for inpatient glycemic control.
Funding to drive development of permanent bioelectronic pacemaker following promising clinical data.

Jim Kaveney writes: “In both entrepreneurship and managing AFib, I have learned that the heart and mind are not in opposition but work together in powerful harmony. Whether navigating the unpredictable rhythms of my heart or the rollercoaster ride of building a business, I discovered that resilience is born from this partnership. By harnessing the power of both, I transformed my pain into purpose, allowing me to overcome the challenges of AFib and entrepreneurship, and ultimately, to help others do the same.”
Christopher Cauble’s view is that the U.S. healthcare market is big enough that good profits can be made without having to bother with the hassle of foreign patent protection, particularly patent protection in China. Read on to learn more.

As an AI researcher and practitioner deeply embedded in the healthcare and life sciences sectors, Dr. Masood sees the passage of California’s SB 1047 as a complex issue with significant implications. He writes this controversial bill, now heading to Governor Newsom’s desk, represents a fundamental misunderstanding of AI as a general-purpose technology. It attempts to regulate the technology itself rather than focusing on specific, problematic applications.
Advanced software tool supports consistent, objective evaluation of lumbar spine MRI scans.
With this approval, ABO Holdings is now operating all six plasma collection centers—two each in California, Utah, and New Jersey.
Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer,
Greg Milosevich joined Danaher in 2010, through the acquisition of Molecular Devices, and since has held roles of increasing responsibility across multiple businesses.
“Deborah Andrews has blended seamlessly with the leadership team, and we quickly realized that her deep knowledge of STAAR and her skills, abilities, and approach made her the perfect choice to be STAAR’s next CFO,” said the Company’s CEO and Board member, Stephen Farrell.

LG Electronics reports: Intended for digital mammography and digital breast tomosynthesis, the 21HQ613D-B is a 21.3-inch 5-megapixel (MP) IPS diagnostic monitor designed to deliver high-definition radiological images and maintains consistent image quality through its internal front calibration sensor and calibration software.

“During complex procedures, it’s vital to be able to rely on surgical imaging systems. As clinicians navigate their way through challenging anatomy, the priority is to quickly visualize small anatomical details while limiting X-ray dose,” said Mark Stoffels, Business Leader Philips Image Guided Therapy Systems. “The new Zenition 90 Motorized empowers medical teams to confidently perform a wide range of interventions while achieving the best possible outcome for their patients.”
VUZE 2.0 provides much-extended interoperability and functionality; like VUZE 1.0, requires only a 2D C-arm and PC in the OR — no cameras, markers, references or tool add-ons.

Virtual Medical Scribing Software: The healthcare industry is constantly changing, and the introduction of medical scribing software is revolutionizing how healthcare professionals operate. With the
IoT in Healthcare: The healthcare industry is rapidly adopting IoT technology. According to a report by MarketsandMarkets, the global market for IoT in healthcare will grow from $127.7 billion in 2023 to $289.2 billion by 2028.
Many employers researching innovative ways to redesign their benefits programs are now looking into ADP’s plans and similar offerings to see how they can deliver a personalized experience without sacrificing business stability.

Integrating EHR and RCM systems created for mental health isn’t just a step up on technology—it is also rethinking care and administration coming together.
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.